REDUCER-I: An Observational Study of the Neovasc Reducer™ System

NCT02710435 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2026-04-03

No results posted yet for this study

Summary

The purpose of this study is to collect long term data of the Reducer System in subjects with refractory angina pectoris.

Conditions

  • Angina Pectoris
  • Angina Pectoris, Stable
  • Chronic Stable Angina

Interventions

DEVICE

Reducer System

An aid in the management of chronic refractory angina pectoris

Sponsors & Collaborators

  • Shockwave Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Stefan Verheye, MD · ZNA Middelheim Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2023-11-30
Completion
2028-12-31

Countries

  • Austria
  • Belgium
  • France
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02710435 on ClinicalTrials.gov